Vertex Pharmaceuticals shared the late-stage study results of its experimental painkiller for acute moderate to severe pain. The drug could give patients a...
10 months ago

The team's deep-learning framework identified multiple gut microbiome-derived metabolites and FDA-approved drugs that can be repurposed to select non-addictive...
1 month ago

A new approach to treating neuropathic pain is making a key step forward thanks to researchers at The University of Texas at Austin.
10 months ago

There's a lot of buzz surrounding the new non-addictive pain pill that is up for FDA approval. It works as well as opioids for treating acute pain,...
6 months ago

Vertex Pharmaceuticals said its experimental painkiller, which is being tested as an alternative to addictive opioids, significantly decreased post-surgery...
10 months ago

Despite their dismal reputation, the aging painkillers are cheap and work better than nonaddictive replacements.
4 months ago

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is looking to be at the forefront of this shift, developing an innovative solution that could reshape chronic...
2 months ago

As the crushing burden of opioid addiction grows, companies such as Latigo Biotherapeutics and Vertex Pharmaceuticals are working to develop new, safer,...
9 months ago

Vertex Pharmaceuticals' non-opioid painkiller significantly decreased pain in patients with diabetes suffering from chronic nerve pain in a mid-stage trial,...
11 months ago

A deep-learning model found metabolites and drugs that could be repurposed for non-addictive and non-opioid options to treat chronic pain.
1 month ago